The Center for Autism and Related Disorders (CARD), Tarzana, Calif, and Lineagen Inc, Salt Lake City, have entered a partnership whereby CARD will offer Lineagen's FirstStepDx® genetic test to patients and their families.
CARD is a provider of early, intensive behavioral intervention for individuals with autism spectrum disorders (ASD)s.
Lineagen is a molecular diagnostics company focused on integrated genetic testing and counseling for individuals with ASDs and other disorders of childhood development. FirstStepDx is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs.
Under the terms of the agreement, FirstStepDx, integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD's innovative Skills® program.
[Source: Lineagen]
 |
 |
 |
 |
CLP is the only magazine that focuses exclusively on products and technology for the clinical lab industry. Every month, CLP's editorial provides 45,000 pathologists, lab managers, administrators and technologists with comprehensive coverage of new products and technology.
RSS